Jinan Transon CNC Equipment Co., Ltd.
S I N C E 2 0 1 0
Latest products
Microfluidic versions of sepsis chip breakthrough in scientific research
by：Transon
2021-01-08
Microfluidic chip we recommend laser equipment factory production equipment, designed for high precision chip to build!
in the university of Illinois recently integrated biomedical/nano technology and application in the laboratory successfully develop microfluidic POCT sepsis chip, only 10 edged up blood sample, the test can be quantitative neutrophilic leukocytes in 30 minutes or so of the total number of white blood cells. Treatment rate is very important for patients with sepsis, but using traditional diagnosis of systemic inflammatory response syndrome standards can be highly nonspecific, and take several days, through rapid analysis of the specific molecular biomarkers, sepsis chips can help to diagnose disease attack faster, it can improve the prognosis of patients.
in order to improve the diagnosis of pertussis method, the research team are developing paper-based microfluidic POCT is suitable for the limited resources of countries/regions. The low cost of biochip estimates only cost a few dollars, it integrates isothermal DNA amplification, the sensitivity and specificity and real-time PCR roughly the same. In less than an hour, could detect the existence of pertussis bacteria through a color change, this method can more quickly than existing methods, more cheaply diagnosed are highly contagious and potentially life-threatening disease.
POCT as one of the most potential field of IVD segment is in rapid growth stage. In order to adapt to a wide application prospect, POCT instrument developers must be considered comprehensively in the process of product research and development products, listing requirements and so on various aspects, including clinical work, product performance and characteristics of regulatory policies and regulations. Especially also want to consider to present electronic medical and big data analysis and other non-traditional components in the field of new spark.
in the university of Illinois recently integrated biomedical/nano technology and application in the laboratory successfully develop microfluidic POCT sepsis chip, only 10 edged up blood sample, the test can be quantitative neutrophilic leukocytes in 30 minutes or so of the total number of white blood cells. Treatment rate is very important for patients with sepsis, but using traditional diagnosis of systemic inflammatory response syndrome standards can be highly nonspecific, and take several days, through rapid analysis of the specific molecular biomarkers, sepsis chips can help to diagnose disease attack faster, it can improve the prognosis of patients.
in order to improve the diagnosis of pertussis method, the research team are developing paper-based microfluidic POCT is suitable for the limited resources of countries/regions. The low cost of biochip estimates only cost a few dollars, it integrates isothermal DNA amplification, the sensitivity and specificity and real-time PCR roughly the same. In less than an hour, could detect the existence of pertussis bacteria through a color change, this method can more quickly than existing methods, more cheaply diagnosed are highly contagious and potentially life-threatening disease.
POCT as one of the most potential field of IVD segment is in rapid growth stage. In order to adapt to a wide application prospect, POCT instrument developers must be considered comprehensively in the process of product research and development products, listing requirements and so on various aspects, including clinical work, product performance and characteristics of regulatory policies and regulations. Especially also want to consider to present electronic medical and big data analysis and other non-traditional components in the field of new spark.
Custom message
